185 related articles for article (PubMed ID: 17537542)
1. The lipopeptides Pal-Lys-Lys-NH(2) and Pal-Lys-Lys soaking alone and in combination with intraperitoneal vancomycin prevent vascular graft biofilm in a subcutaneous rat pouch model of staphylococcal infection.
Cirioni O; Giacometti A; Ghiselli R; Kamysz W; Silvestri C; Orlando F; Mocchegiani F; Vittoria AD; Kamysz E; Saba V; Scalise G
Peptides; 2007 Jun; 28(6):1299-303. PubMed ID: 17537542
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic efficacy of topical temporin A and RNAIII-inhibiting peptide in a subcutaneous rat Pouch model of graft infection attributable to staphylococci with intermediate resistance to glycopeptides.
Cirioni O; Giacometti A; Ghiselli R; Dell'Acqua G; Gov Y; Kamysz W; Lukasiak J; Mocchegiani F; Orlando F; D'Amato G; Balaban N; Saba V; Scalise G
Circulation; 2003 Aug; 108(6):767-71. PubMed ID: 12885754
[TBL] [Abstract][Full Text] [Related]
3. The prophylactic efficacy of rifampicin-soaked graft in combination with systemic vancomycin in the prevention of prosthetic vascular graft infection: an experimental study.
Sacar M; Goksin I; Baltalarli A; Turgut H; Sacar S; Onem G; Ozcan V; Adali F
J Surg Res; 2005 Dec; 129(2):329-34. PubMed ID: 16360378
[TBL] [Abstract][Full Text] [Related]
4. Vascular graft infection by Staphylococcus aureus: efficacy of cefazolin, teicoplanin and vancomycin prophylaxis protocols in a rat model.
Atahan E; Gul M; Ergun Y; Eroglu E
Eur J Vasc Endovasc Surg; 2007 Aug; 34(2):182-7. PubMed ID: 17481929
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic efficacy of linezolid alone or combined with levofloxacin and vancomycin in a rat subcutaneous pouch model of graft infection caused by Staphylococcus epidermidis with intermediate resistance to glycopeptides.
Giacometti A; Ghiselli R; Cirioni O; Mocchegiani F; Orlando F; Del Prete MS; D'Amato G; Silvestri C; Saba V; Scalise G
J Antimicrob Chemother; 2003 Oct; 52(4):724-6. PubMed ID: 12951347
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of vancomycin, teicoplanin and fusidic acid as prophylactic agents in prevention of vascular graft infection: an experimental study in rat.
Yasim A; Gul M; Atahan E; Ciragil P; Aral M; Ergun Y
Eur J Vasc Endovasc Surg; 2006 Mar; 31(3):274-9. PubMed ID: 16360328
[TBL] [Abstract][Full Text] [Related]
7. Prophylaxis against Staphylococcus aureus vascular graft infection with mupirocin-soaked, collagen-sealed dacron.
Ghiselli R; Giacometti A; Goffi L; Cirioni O; Mocchegiani F; Orlando F; Paggi AM; Petrelli E; Scalise G; Saba V
J Surg Res; 2001 Aug; 99(2):316-20. PubMed ID: 11469904
[TBL] [Abstract][Full Text] [Related]
8. Quorum sensing inhibitor FS3-coated vascular graft enhances daptomycin efficacy in a rat model of staphylococcal infection.
Cirioni O; Mocchegiani F; Cacciatore I; Vecchiet J; Silvestri C; Baldassarre L; Ucciferri C; Orsetti E; Castelli P; Provinciali M; Vivarelli M; Fornasari E; Giacometti A
Peptides; 2013 Feb; 40():77-81. PubMed ID: 23262356
[TBL] [Abstract][Full Text] [Related]
9. Daptomycin and rifampin alone and in combination prevent vascular graft biofilm formation and emergence of antibiotic resistance in a subcutaneous rat pouch model of staphylococcal infection.
Cirioni O; Mocchegiani F; Ghiselli R; Silvestri C; Gabrielli E; Marchionni E; Orlando F; Nicolini D; Risaliti A; Giacometti A
Eur J Vasc Endovasc Surg; 2010 Dec; 40(6):817-22. PubMed ID: 20869272
[TBL] [Abstract][Full Text] [Related]
10. Linezolid alone and in combination with rifampicin prevents experimental vascular graft infection due to methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis.
Sacar M; Sacar S; Kaleli I; Onem G; Turgut H; Goksin I; Ozcan V; Kaan Inan B; Duver H; Baltalarli A
J Surg Res; 2007 May; 139(2):170-5. PubMed ID: 17292421
[TBL] [Abstract][Full Text] [Related]
11. RNAIII-inhibiting peptide and/or nisin inhibit experimental vascular graft infection with methicillin-susceptible and methicillin-resistant Staphylococcus epidermidis.
Ghiselli R; Giacometti A; Cirioni O; Dell'Acqua G; Mocchegiani F; Orlando F; D'Amato G; Rocchi M; Scalise G; Saba V
Eur J Vasc Endovasc Surg; 2004 Jun; 27(6):603-7. PubMed ID: 15121110
[TBL] [Abstract][Full Text] [Related]
12. BMAP-28 improves the efficacy of vancomycin in rat models of gram-positive cocci ureteral stent infection.
Orlando F; Ghiselli R; Cirioni O; Minardi D; Tomasinsig L; Mocchegiani F; Silvestri C; Skerlavaj B; Riva A; Muzzonigro G; Saba V; Scalise G; Zanetti M; Giacometti A
Peptides; 2008 Jul; 29(7):1118-23. PubMed ID: 18430491
[TBL] [Abstract][Full Text] [Related]
13. Regional antibiotic delivery for the treatment of experimental prosthetic graft infections.
Keeling WB; Myers AR; Stone PA; Heller L; Widen R; Back MR; Johnson BL; Bandyk DF; Shames ML
J Surg Res; 2009 Dec; 157(2):223-6. PubMed ID: 19560786
[TBL] [Abstract][Full Text] [Related]
14. Sustained release of vancomycin from a new biodegradable glue to prevent methicillin-resistant Staphylococcus aureus graft infection.
Morishima M; Marui A; Yanagi S; Nomura T; Nakajima N; Hyon SH; Ikeda T; Sakata R
Interact Cardiovasc Thorac Surg; 2010 Jul; 11(1):52-5. PubMed ID: 20360210
[TBL] [Abstract][Full Text] [Related]
15. Citropin 1.1-treated central venous catheters improve the efficacy of hydrophobic antibiotics in the treatment of experimental staphylococcal catheter-related infection.
Cirioni O; Giacometti A; Ghiselli R; Kamysz W; Orlando F; Mocchegiani F; Silvestri C; Licci A; Chiodi L; Lukasiak J; Saba V; Scalise G
Peptides; 2006 Jun; 27(6):1210-6. PubMed ID: 16289474
[TBL] [Abstract][Full Text] [Related]
16. Impact of biofilm on the in vitro activity of vancomycin alone and in combination with tigecycline and rifampicin against Staphylococcus aureus.
Rose WE; Poppens PT
J Antimicrob Chemother; 2009 Mar; 63(3):485-8. PubMed ID: 19109338
[TBL] [Abstract][Full Text] [Related]
17. RNAIII-inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated Staphylococcus aureus infections.
Cirioni O; Giacometti A; Ghiselli R; Dell'Acqua G; Orlando F; Mocchegiani F; Silvestri C; Licci A; Saba V; Scalise G; Balaban N
J Infect Dis; 2006 Jan; 193(2):180-6. PubMed ID: 16362881
[TBL] [Abstract][Full Text] [Related]
18. The efficacy of the quorum sensing inhibitor FS8 and tigecycline in preventing prosthesis biofilm in an animal model of staphylococcal infection.
Simonetti O; Cirioni O; Mocchegiani F; Cacciatore I; Silvestri C; Baldassarre L; Orlando F; Castelli P; Provinciali M; Vivarelli M; Fornasari E; Giacometti A; Offidani A
Int J Mol Sci; 2013 Aug; 14(8):16321-32. PubMed ID: 23965956
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of rifampin-levofloxacin as a prophylactic agent in preventing Staphylococcus epidermidis graft infection.
Ghiselli R; Giacometti A; Goffi L; Cirioni O; Boccoli G; Mocchegiani F; Riva A; Scalise G; Saba V
Eur J Vasc Endovasc Surg; 2000 Dec; 20(6):508-11. PubMed ID: 11136585
[TBL] [Abstract][Full Text] [Related]
20. BisEDT and RIP act in synergy to prevent graft infections by resistant staphylococci.
Domenico P; Gurzenda E; Giacometti A; Cirioni O; Ghiselli R; Orlando F; Korem M; Saba V; Scalise G; Balaban N
Peptides; 2004 Dec; 25(12):2047-53. PubMed ID: 15572191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
